These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 31445233)

  • 21. Synthesis, docking simulation, biological evaluations and 3D-QSAR study of 5-Aryl-6-(4-methylsulfonyl)-3-(metylthio)-1,2,4-triazine as selective cyclooxygenase-2 inhibitors.
    Irannejad H; Kebriaieezadeh A; Zarghi A; Montazer-Sadegh F; Shafiee A; Assadieskandar A; Amini M
    Bioorg Med Chem; 2014 Jan; 22(2):865-73. PubMed ID: 24361187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and anti-inflammatory assessment of certain substituted 1,2,4-triazoles bearing tetrahydroisoquinoline scaffold as COX 1/2-inhibitors.
    Abo-Elmagd MI; Hassan RM; Aboutabl ME; Amin KM; El-Azzouny AA; Aboul-Enein MN
    Bioorg Chem; 2024 Sep; 150():107577. PubMed ID: 38941697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New imidazolone derivatives comprising a benzoate or sulfonamide moiety as anti-inflammatory and antibacterial inhibitors: Design, synthesis, selective COX-2, DHFR and molecular-modeling study.
    Metwally NH; Mohamed MS
    Bioorg Chem; 2020 Jun; 99():103438. PubMed ID: 31796216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel 1,3,4-oxadiazole/oxime hybrids: Synthesis, docking studies and investigation of anti-inflammatory, ulcerogenic liability and analgesic activities.
    Abd-Ellah HS; Abdel-Aziz M; Shoman ME; Beshr EA; Kaoud TS; Ahmed AF
    Bioorg Chem; 2016 Dec; 69():48-63. PubMed ID: 27669120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, COX-2 inhibition, anti-inflammatory activity, molecular docking, and histopathological studies of new pyridazine derivatives.
    Ewieda SY; Hassan RA; Ahmed EM; Abdou AM; Hassan MSA
    Bioorg Chem; 2024 Sep; 150():107623. PubMed ID: 39002251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and molecular docking of new imidazoquinazolinones as analgesic agents and selective COX-2 inhibitors.
    Hassanein HH; Georgey HH; Fouad MA; El Kerdawy AM; Said MF
    Future Med Chem; 2017 Apr; 9(6):553-578. PubMed ID: 28394629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, evaluation and molecular modelling studies of some novel 5,6-diphenyl-1,2,4-triazin-3(2H)-ones bearing five-member heterocyclic moieties as potential COX-2 inhibitors: A hybrid pharmacophore approach.
    Banerjee AG; Das N; Shengule SA; Sharma PA; Srivastava RS; Shrivastava SK
    Bioorg Chem; 2016 Dec; 69():102-120. PubMed ID: 27750057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1,4-Dihydroquinazolin-3(2H)-yl benzamide derivatives as anti-inflammatory and analgesic agents with an improved gastric profile: Design, synthesis, COX-1/2 inhibitory activity and molecular docking study.
    Sakr A; Kothayer H; Ibrahim SM; Baraka MM; Rezq S
    Bioorg Chem; 2019 Mar; 84():76-86. PubMed ID: 30481648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benzodioxole-Pyrazole Hybrids as Anti-Inflammatory and Analgesic Agents with COX-1,2/5-LOX Inhibition and Antioxidant Potential.
    Abd El Razik HA; Badr MH; Atta AH; Mouneir SM; Abu-Serie MM
    Arch Pharm (Weinheim); 2017 May; 350(5):. PubMed ID: 28418202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, in-vitro, in-vivo anti-inflammatory activities and molecular docking studies of acyl and salicylic acid hydrazide derivatives.
    Munir A; Khushal A; Saeed K; Sadiq A; Ullah R; Ali G; Ashraf Z; Ullah Mughal E; Saeed Jan M; Rashid U; Hussain I; Mumtaz A
    Bioorg Chem; 2020 Nov; 104():104168. PubMed ID: 32947133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, biological evaluation, and docking studies of 3-(substituted)-aryl-5-(9-methyl-3-carbazole)-1H-2-pyrazolines as potent anti-inflammatory and antioxidant agents.
    Bandgar BP; Adsul LK; Chavan HV; Jalde SS; Shringare SN; Shaikh R; Meshram RJ; Gacche RN; Masand V
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5839-44. PubMed ID: 22901385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of new nicotinate derivatives as potential anti-inflammatory agents targeting COX-2 enzyme.
    El-Dash Y; Khalil NA; Ahmed EM; Hassan MSA
    Bioorg Chem; 2021 Feb; 107():104610. PubMed ID: 33454504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and biological evaluations of novel isoxazoles and furoxan derivative as anti-inflammatory agents.
    Abdelall EKA
    Bioorg Chem; 2020 Jan; 94():103441. PubMed ID: 31859011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New methyl 5-(halomethyl)-1-aryl-1H-1,2,4-triazole-3-carboxylates as selective COX-2 inhibitors and anti-inflammatory agents: Design, synthesis, biological evaluation, and docking study.
    Li SM; Tsai SE; Chiang CY; Chung CY; Chuang TJ; Tseng CC; Jiang WP; Huang GJ; Lin CY; Yang YC; Fuh MT; Wong FF
    Bioorg Chem; 2020 Nov; 104():104333. PubMed ID: 33142408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel tetrazole-based selective COX-2 inhibitors: Design, synthesis, anti-inflammatory activity, evaluation of PGE
    Labib MB; Fayez AM; El-Nahass ES; Awadallah M; Halim PA
    Bioorg Chem; 2020 Nov; 104():104308. PubMed ID: 33011534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug Design, Synthesis and Biological Evaluation of Heterocyclic Molecules as Anti-Inflammatory Agents.
    Savjani J; Variya B; Patel S; Mulamkattil S; Amin H; Butani S; Allam A; Ajarem J; Shah H
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, anti-inflammatory, analgesic, COX1/2-inhibitory activity, and molecular docking studies of hybrid pyrazole analogues.
    Alam MJ; Alam O; Khan SA; Naim MJ; Islamuddin M; Deora GS
    Drug Des Devel Ther; 2016; 10():3529-3543. PubMed ID: 27826185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, in vitro and in vivo biological evaluation, COX-1/2 inhibition and molecular docking study of indole-N-acylhydrazone derivatives.
    Moraes ADTO; Miranda MDS; Jacob ÍTT; Amorim CADC; Moura RO; Silva SÂSD; Soares MBP; Almeida SMV; Souza TRCL; Oliveira JF; Silva TGD; Melo CML; Moreira DRM; Lima MDCA
    Bioorg Med Chem; 2018 Nov; 26(20):5388-5396. PubMed ID: 30293795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New 1,2-diaryl-4-substituted-benzylidene-5-4H-imidazolone derivatives: Design, synthesis and biological evaluation as potential anti-inflammatory and analgesic agents.
    Abdellatif KRA; Fadaly WAA
    Bioorg Chem; 2017 Jun; 72():123-129. PubMed ID: 28411407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New indomethacin analogs as selective COX-2 inhibitors: Synthesis, COX-1/2 inhibitory activity, anti-inflammatory, ulcerogenicity, histopathological, and docking studies.
    Abdellatif KRA; Abdelall EKA; Elshemy HAH; El-Nahass ES; Abdel-Fattah MM; Abdelgawad YYM
    Arch Pharm (Weinheim); 2021 Apr; 354(4):e2000328. PubMed ID: 33314237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.